NCT07171658Recruiting
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Improving Cervical Cancer Screening Coverage Among Underscreened Women Aged 50 to 74 in Switzerland Using HPV Self-sampling Strategies: A Randomized Study - Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland. This randomized trial will compare three arms: 1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment. 2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection 3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 4500 (estimated)
- First submitted
- 25 Aug 2025
- Start date
- 7 Oct 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Jessica Di Vincenzo Sormani
- Diseases
- Cervical cancer
- NCT number
- NCT07171658
What you commit to
- Study type: Interventional
- Planned participants: 4500
- From 7 Oct 2025 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior cervical cancer diagnosis,
Other
- Hysterectomy
- Non consent to participate to the study
- Incapable of judgment or under tutelage
- Pregnancy
Who the study is looking for
- Women receiving Breast Cancer Screening (BCS) invitation letters in the selected five cantons (Geneva, Bern (francophone), Jura, Neuchâtel, and Vaud)
- Aged 50 to 74 years old
- Not been screened for cervical cancer in the past three years
- Speaking one of the 6 languages of the study (French, German, Italian, and in English, Spanish, and Portuguese)
Age in the registry: 50 years to 74 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals of Geneva Coordinator of this site? Confirm its status | Geneva | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.